KVA

K V Pharma CL A (KVA)

K V Pharma CL A

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NYSE:KVA

1 2 3 4 5 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2012/06/18	22:04	Dow Jones News	U.S. HOT STOCK FUTURES: HOT STOCKS to WATCH	NYSE:KVA	K V Pharma CL A
2012/06/18	20:08	Dow Jones News	U.S. HOT STOCK FUTURES: HOT STOCKS to WATCH	NYSE:KVA	K V Pharma CL A
2011/11/17	10:15	Business Wire	Glancy Binkow & Goldberg LLP Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against K-V Pharmaceutical Company	NYSE:KVA	K V Pharma CL A
2011/11/03	10:40	Business Wire	Law Offices of Howard G. Smith Announces Class Action Lawsuit Against K-V Pharmaceutical Company	NYSE:KVA	K V Pharma CL A
2011/11/01	10:30	Business Wire	Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against K-V Pharmaceutical Company	NYSE:KVA	K V Pharma CL A
2011/10/29	05:30	Business Wire	Faruqi & Faruqi, LLP Announces Investigation of K-V Pharmaceutical Company	NYSE:KVA	K V Pharma CL A
2011/10/25	02:52	Business Wire	The Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of K-V Pharmaceutical Company	NYSE:KVA	K V Pharma CL A
2011/10/21	09:47	Business Wire	Law Offices of Howard G. Smith Announces Class Action Lawsuit Against K-V Pharmaceutical Company	NYSE:KVA	K V Pharma CL A
2011/10/13	22:02	Business Wire	Zeldes & Haeggquist, LLP Announces Investigation of K-V Pharmaceutical	NYSE:KVA	K V Pharma CL A
2011/06/13	21:00	PR Newswire (US)	K-V Pharmaceutical Company Announces Filing of Fiscal 2011 Form 10-K and Schedules Investor Conference Call	NYSE:KVA	K V Pharma CL A
2011/04/02	04:08	Dow Jones News	UPDATE: K-V Pharma Slashes Price Of Preterm Labor Drug Amid Outcry	NYSE:KVA	K V Pharma CL A
2011/04/01	23:28	Dow Jones News	K-V Pharma Slashes Prices Of Preterm Labor Drug After FDA Move	NYSE:KVA	K V Pharma CL A
2011/04/01	06:28	Dow Jones News	Religious Groups Urge Drug Makers To Ease Up On Price Hikes	NYSE:KVA	K V Pharma CL A
2011/03/31	04:58	Dow Jones News	UPDATE: K-V Pharma Shares Drop On FDA Statement On Preterm Birth Drug	NYSE:KVA	K V Pharma CL A
2011/03/31	01:38	Dow Jones News	K-V Pharma Shares Drop On FDA Statement On Preterm Birth Drug	NYSE:KVA	K V Pharma CL A
2011/03/01	22:49	PR Newswire (US)	K-V Pharmaceutical Company Announces $200 Million Private Debt Offering	NYSE:KVA	K V Pharma CL A
2011/02/15	00:36	PR Newswire (US)	KV Pharmaceutical Company Announces Delay In Conference Call and Provides Overview Of Conference Call Comments	NYSE:KVA	K V Pharma CL A
2011/02/15	00:34	PR Newswire (US)	K-V Pharmaceutical Company Announces Reliance on the Financial Distress Exception to NYSE's Shareholder Approval Policy to Issue	NYSE:KVA	K V Pharma CL A
2011/02/14	23:48	PR Newswire (US)	K-V Pharmaceutical Company Announces Completion of a $32 Million Private Placement of Class A Common Stock	NYSE:KVA	K V Pharma CL A
2011/02/04	22:40	PR Newswire (US)	K-V Pharmaceutical Company to Host Investor Conference Call on February 14, 2011	NYSE:KVA	K V Pharma CL A
2011/01/12	23:03	PR Newswire (US)	K-V Pharmaceutical Company Updates Status of New Drug Application for Gestiva™	NYSE:KVA	K V Pharma CL A
2010/09/14	23:29	Dow Jones News	K-V Pharmaceutical Enters Loan Agreement In Wake Of FDA Approval	NYSE:KVA	K V Pharma CL A
2010/09/10	22:53	Dow Jones News	K-V Pharma Soars On FDA Approval To Return Product To Market	NYSE:KVA	K V Pharma CL A
2010/02/26	03:53	PR Newswire (US)	KV Pharmaceutical Reaches Agreement with U.S. Department of Justice	NYSE:KVA	N^CURN
2010/01/29	07:04	Business Wire	Robbins Umeda LLP Announces Investigation of KV Pharmaceutical Company	NYSE:KVA	K V Pharma CL A
2010/01/21	05:41	Dow Jones News	UPDATE: Watson Pharma Benefits From Toprol Market Presence	NYSE:KVA	K V Pharma CL A
2010/01/21	04:11	Dow Jones News	Watson Pharma Continues To Benefit From Toprol Market Presence	NYSE:KVA	K V Pharma CL A
2010/01/11	23:18	PR Newswire (US)	KV Pharmaceutical Amends Agreement to Secure Rights to Gestiva(TM)	NYSE:KVA
2010/01/08	06:10	PR Newswire (US)	KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes to Approve Appointment of Director	NYSE:KVA
2009/12/23	07:34	PR Newswire (US)	KV Pharmaceutical Receives Permission from NYSE for its Securities to Continue Trading on the NYSE until March 31, 2010	NYSE:KVA